A
Andreas M. Pleil
Researcher at Pfizer
Publications - 57
Citations - 2229
Andreas M. Pleil is an academic researcher from Pfizer. The author has contributed to research in topics: Macular degeneration & Population. The author has an hindex of 17, co-authored 56 publications receiving 1899 citations.
Papers
More filters
Journal ArticleDOI
Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis
Usha Chakravarthy,Tien Yin Wong,Tien Yin Wong,Astrid E. Fletcher,Elisabeth Piault,Christopher M. Evans,Gergana Zlateva,Ronald Buggage,Andreas M. Pleil,Paul Mitchell +9 more
TL;DR: Increasing age, current cigarette smoking, previous cataract surgery, and a family history of AMD showed strong and consistent associations with late AMD.
Journal ArticleDOI
Pediatric Patient-Reported Outcome Instruments for Research to Support Medical Product Labeling: Report of the ISPOR PRO Good Research Practices for the Assessment of Children and Adolescents Task Force
Louis S. Matza,Donald L. Patrick,Anne W. Riley,John J. Alexander,Luis Rajmil,Andreas M. Pleil,Monika Bullinger +6 more
TL;DR: This task force report identifies factors to consider when making decisions about the design and use of pediatric PRO instruments, while highlighting issues that require further research.
Journal ArticleDOI
Rates of progression in diabetic retinopathy during different time periods: a systematic review and meta-analysis.
Tien Yin Wong,Mkaya Mwamburi,Ronald Klein,Michael Larsen,Harry Flynn,Marisol Hernandez-Medina,Gayatri Ranganathan,Barbara M Wirostko,Andreas M. Pleil,Paul Mitchell +9 more
TL;DR: Since 1985, diabetic patients have lower rates of progression to PDR and SVL, which may reflect an increased awareness of retinopathy risk factors; earlier identification and initiation of care for patients withretinopathy; and improved medical management of glucose, blood pressure, and serum lipids.
Journal ArticleDOI
Multinational study of reliability and validity of the King's Health Questionnaire in patients with overactive bladder.
TL;DR: Psychometric testing supports the reliability and validity of the KHQ as an OAB-specific measure of HRQoL and it is externally valid and consistent.
Journal ArticleDOI
How much is enough and who says so
TL;DR: This research highlights the need to translate statistically significant health‐related quality of life changes into interpretable clinical or medically important ones in order to provide real-time information about disease progression.